{"id":178661,"date":"2026-07-31T11:33:40","date_gmt":"2026-07-31T06:03:40","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=178661"},"modified":"2026-07-31T11:33:40","modified_gmt":"2026-07-31T06:03:40","slug":"emcure-pharmaceuticals-ltd-share-price-52-week-high-today","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-ltd-share-price-52-week-high-today\/","title":{"rendered":"Emcure Pharmaceuticals Ltd. (EMCURE) Share Price Hits 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;;margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/emcure\/emcure-pharmaceuticals-ltd-share-price-today\">Emcure Pharmaceuticals Ltd.<\/a> Share Price reached a fresh 52-week high of Rs 1959.15, rising 2.35% today, with a market cap of Rs 36,130.27 crore.<\/p>\n<p style=\"margin-top:0!important;;margin-top:0!important;\">Emcure Pharmaceuticals Ltd. Share Price has reached a fresh 52-week high of Rs 1959.15, marking a 2.35% increase from the previous close of Rs 1909.95. The company&#8217;s market capitalisation now stands at Rs 36,130.27 crore. This milestone highlights the stock&#8217;s recent momentum in the market, drawing investor attention. The healthcare sector, where Emcure operates, remains a significant focus for investors, contributing to the stock&#8217;s positive performance. Univest continues to monitor Emcure Pharmaceuticals Ltd. Share Price for further developments.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Emcure_Pharmaceuticals_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Emcure Pharmaceuticals Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,954.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,909.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 44.85 (+2.35%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,934.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,959.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,905<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1,664<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.33 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 36,130.27 crore<\/td>\n<\/tr>\n<\/table>\n<p>Emcure Pharmaceuticals Ltd. (EMCURE) traded at Rs 1,954.8. versus the previous close of Rs 1,909.95, a rise of 2.35%. The stock opened at Rs 1,934.35, reached Rs 1,959.15, touched Rs 1,905. Reported volume was 1,664.<\/p>\n<p>Today, Emcure Pharmaceuticals Ltd. opened at Rs 1934.35 and reached a high of Rs 1959.15, setting a new 52-week high. The stock&#8217;s low for the day was Rs 1905, with a turnover of Rs 0.33 crore. The current volume of 1664 indicates active trading, although it remains a small fraction of the company&#8217;s overall market cap. The 2.35% rise from the previous close underscores the stock&#8217;s upward momentum, capturing market interest.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Emcure_Pharmaceuticals_Ltd_EMCURE_Fundamental_Analysis\"><\/span><strong>Emcure Pharmaceuticals Ltd. (EMCURE) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 36,130.27 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">39.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.93x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.35%<\/td>\n<\/tr>\n<\/table>\n<p>Emcure Pharmaceuticals Ltd. was valued at a P\/E ratio of 39.17x, a P\/B ratio of 7.93x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">39.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.13x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">73.73x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 3,417.8x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.93x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.92x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.73%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 36,130.27 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 140.91 crore<\/td>\n<\/tr>\n<\/table>\n<p>Emcure Pharmaceuticals Ltd. (EMCURE) is classified under sector: Healthcare.<\/p>\n<p>Emcure Pharmaceuticals Ltd. (EMCURE) has a P\/E ratio of 39.17x, which is above the benchmark median of 20.13x, a difference of +94.59%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Emcure Pharmaceuticals Ltd. (EMCURE) has a ROE of 28.21%, which is above the benchmark median of 10.73%, a difference of +162.91%. Emcure Pharmaceuticals Ltd. (EMCURE) has a ROCE of 26.35%, which is above the benchmark median of 13.2%, a difference of +99.62%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,700.98<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,475.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">58.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,439.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">165.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,424.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/venusrem\/venus-remedies-ltd-share-price-today\"><strong>Venus Remedies Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">VENUSREM-BE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,150.28<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.01<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.89<\/td>\n<\/tr>\n<\/table>\n<p>Emcure Pharmaceuticals Ltd. (EMCURE) has a P\/E ratio of 39.17x compared with the displayed peer median of 39.17x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Emcure Pharmaceuticals Ltd. (EMCURE) has a market capitalisation of Rs 36,130.27 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Emcure_Pharmaceuticals_Ltd\"><\/span><strong>Why Investors Are Watching Emcure Pharmaceuticals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Emcure Pharmaceuticals Ltd. Share Price reached a fresh 52-week high, indicating strong market momentum.<\/li>\n<li>The company&#8217;s fundamentals, including high ROE and ROCE, highlight its financial strength.<\/li>\n<li>Emcure&#8217;s premium valuation reflects investor confidence in its growth prospects.<\/li>\n<li>The healthcare sector&#8217;s performance supports Emcure&#8217;s market position.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Emcure_Pharmaceuticals_Ltd\"><\/span><strong>About Emcure Pharmaceuticals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Emcure Pharmaceuticals Ltd. is a leading player in the healthcare sector, focusing on the development, manufacturing, and marketing of a broad range of pharmaceutical products. The company operates in various therapeutic segments, providing innovative solutions to healthcare challenges. Emcure&#8217;s commitment to quality and innovation has established it as a trusted name in the industry, serving both domestic and international markets. With a strong pipeline and a focus on research and development, Emcure continues to expand its product offerings and market reach.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Emcure_Pharmaceuticals_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Emcure Pharmaceuticals Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/emcure\/emcure-pharmaceuticals-ltd-share-price-today\">Emcure Pharmaceuticals Ltd. (EMCURE) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Investors can track Emcure Pharmaceuticals Ltd. Share Price, technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights on Univest. Stay informed with the latest data and analysis to make informed investment decisions.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Emcure_Pharmaceuticals_Ltd\"><\/span><strong>What is the current share price of Emcure Pharmaceuticals Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The current share price of Emcure Pharmaceuticals Ltd. is Rs 1954.8, marking a 2.35% increase from the previous close. The stock moved 2.35% during the session. The intraday range extended from Rs 1,905 to Rs 1,959.15.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Emcure_Pharmaceuticals_Ltds_market_capitalisation\"><\/span><strong>What is Emcure Pharmaceuticals Ltd.&#39;s market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals Ltd.&#39;s market capitalisation is Rs 36,130.27 crore, reflecting its significant presence in the healthcare sector. The company operates in the Healthcare sector. Its P\/E ratio is 39.17x. ROE is 28.21% and ROCE is 26.35%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Emcure_Pharmaceuticals_Ltds_PE_ratio_compare_to_the_sector_median\"><\/span><strong>How does Emcure Pharmaceuticals Ltd.&#39;s P\/E ratio compare to the sector median?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals Ltd.&#39;s P\/E ratio of 39.17 is above the sector median of 20.13, indicating a relatively higher valuation. The company trades at a P\/E ratio of 39.17x. Its P\/B ratio is 7.93x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52-week_high_of_Emcure_Pharmaceuticals_Ltd\"><\/span><strong>What is the 52-week high of Emcure Pharmaceuticals Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52-week high of Emcure Pharmaceuticals Ltd. is Rs 1959.15, achieved on 31 July 2026. The stock moved 2.35% during the session. The intraday range extended from Rs 1,905 to Rs 1,959.15.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Emcure_Pharmaceuticals_Ltds_ROE_compare_to_the_sector_median\"><\/span><strong>How does Emcure Pharmaceuticals Ltd.&#39;s ROE compare to the sector median?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals Ltd.&#39;s ROE of 28.21% is significantly higher than the sector median of 10.73%, showcasing strong profitability. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.73%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Emcure_Pharmaceuticals_Ltds_PB_ratio\"><\/span><strong>What is Emcure Pharmaceuticals Ltd.&#39;s P\/B ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals Ltd.&#39;s P\/B ratio is 7.93, which is above the sector median of 1.92, indicating a premium valuation. The company trades at a P\/E ratio of 39.17x. Its P\/B ratio is 7.93x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Who_are_Emcure_Pharmaceuticals_Ltds_peers\"><\/span><strong>Who are Emcure Pharmaceuticals Ltd.&#39;s peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals Ltd.&#39;s peers include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., and Sai Parenteral&#39;s Ltd., among others. Comparable listed companies include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Sai Parenteral&#39;s Ltd.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Emcure_Pharmaceuticals_Ltds_ROCE\"><\/span><strong>What is Emcure Pharmaceuticals Ltd.&#39;s ROCE?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals Ltd.&#39;s ROCE is 26.35%, indicating efficient capital use and strong operational performance. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.73%. The relevant peer median ROCE is 13.2%.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Emcure Pharmaceuticals Ltd. Share Price hits a new 52-week high at Rs 1,954.8. marking a 2.35% rise today. Market cap stands at Rs 36,130.27 crore.<\/p>\n","protected":false},"author":29,"featured_media":178659,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-178661","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["178659"],"rank_math_title":["Emcure Pharmaceuticals Ltd. Share Price Hits 52-Week High"],"rank_math_description":["Emcure Pharmaceuticals Ltd. Share Price hits a fresh 52-week high at Rs 1959.15. Explore price action, fundamentals, and sector analysis."],"rank_math_focus_keyword":["Emcure Pharmaceuticals Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Emcure_Pharmaceuticals_Ltd_EMCURE_Share_Price_Hits_52_Week_High_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/178661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=178661"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/178661\/revisions"}],"predecessor-version":[{"id":178662,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/178661\/revisions\/178662"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/178659"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=178661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=178661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=178661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}